Heterotypic signaling between epithelial tumor cells and fibroblasts in carcinoma formation

Experimental Cell Research

Volumn 264, Issue 1, 2001, Pages 169-184

  Elenbaas, Brian ^a   Weinberg, Robert A ^a  

^a WHITEHEAD INSTITUTE FOR BIOMEDICAL RESEARCH   (United States)

Author keywords

Breast; Carcinoma; Desmoplasia; Epithelial; Fibroblast; Myofibroblast; Paracrine; Stroma; Tumor

Indexed keywords

CANCER INVASION; CARCINOGENESIS; CARCINOMA; CELL INTERACTION; EPITHELIUM TUMOR; FIBROBLAST; GENE MUTATION; HUMAN; NONHUMAN; PARACRINE SIGNALING; PRIORITY JOURNAL; REVIEW; SIGNAL TRANSDUCTION; TUMOR GROWTH;

EID: 0035835829     PISSN: 00144827     EISSN: None     Source Type: Journal    
DOI: 10.1006/excr.2000.5133     Document Type: Article

References (131)

1. Role of mesenchymal-epithelial interactions in normal and abnormal development of the mammary gland and prostate
2. The influence of tissue microenvironment (stroma and extracellular matrix) on the development and function of mammary epithelium
3. Tumors: Wounds that do not heal. Similarities between tumor stroma generation and wound healing
4. Stromal myofibroblasts in primary invasive and metastatic carcinomas. A combined immunological, light and electron microscopic study
5. Distribution of the major connective matrix components of the stromal reaction in breast carcinoma. An immunohistochemical study
6. Smooth-muscle differentiation in stromal cells of malignant and non-malignant breast tissues
7. Cellular changes involved in conversion of normal to malignant breast: Importance of the stromal reaction
8. Expression of smooth muscle-specific proteins in myoepithelium and stromal myofibroblasts of normal and malignant human breast tissue
9. The origin of the myofibroblasts in breast cancer. Recapitulation of tumor environment in culture unravels diversity and implicates converted fibroblasts and recruited smooth muscle cells
10. The myofibroblast: A quarter century after its discovery
11. Transforming growth factor beta 1 is present at sites of extracellular matrix gene expression in human pulmonary fibrosis
12. Modulation of actin isoform expression in alveolar myofibroblasts (contractile interstitial cells) during pulmonary hypertension
13. Alpha-smooth muscle actin in parenchymal cells of bleomycin-injured rat lung
14. Fetal myofibroblast-like cells isolated from post-radiation fibrosis in human breast cancer
15. Myofibroblasts in soft tissue sarcomas
16. Carcinoma-associated fibroblasts direct tumor progression of initiated human prostatic epithelium
17. Matrix metalloproteinases are expressed during ductal and alveolar mammary morphogenesis, and misregulation of stromelysin-1 in transgenic mice induces unscheduled alveolar development
18. Targeted expression of stromelysin-1 in mammary gland provides evidence for a role of proteinases in branching morphogenesis and the requirement for an intact basement membrane for tissue-specific gene expression
19. Expression of autoactivated stromelysin-1 in mammary glands of transgenic mice leads to a reactive stroma during early development
20. The stromal proteinase MMP3/stromelysin-1 promotes mammary carcinogenesis
21. Orthotopic implantation is essential for the selection, growth and metastasis of human renal cell cancer in nude mice
22. Preferential growth of mammary tumors in intact mammary fat-pads
23. Tumorigenicity and metastasis of human breast carcinoma cell lines in nude mice
24. Irradiated mammary gland stroma promotes the expression of tumorigenic potential by unirradiated epithelial cells
25. Human breast cancer cells generated by oncogenic transformation of primary mammary epithelial cells
26. Enhancement of tumorigenicity of human breast adenocarcinoma cells in nude mice by Matrigel and fibroblasts
27. Fibroblast-mediated acceleration of human epithelial tumor growth in vivo
28. Fibroblast-dependent tumorigenicity of cells in nude mice: Implication for implantation of metastases
29. Mitogenicity of human fibroblasts in vivo for human breast cancer cells
30. Growth and metastasis of human breast carcinomas with Matrigel in athymic mice
31. Vascular stroma formation in carcinoma in situ, invasive carcinoma, and metastatic carcinoma of the breast
32. The mammary gland: A unique organ for the study of development and tumorigenesis
33. Think globally, act locally: The making of a mouse mammary gland
34. Role of transforming growth factor beta in human disease
35. The role for transforming growth factor-beta (TGF-beta) in human cancer
36. Transforming growth factor beta and cancer
37. Immunohistochemical staining for transforming growth factor beta 1 associates with disease progression in human breast cancer
38. Anti-transforming growth factor (TGF)-beta antibodies inhibit breast cancer cell tumorigenicity and increase mouse spleen natural killer cell activity. Implications for a possible role of tumor cell/host TGF-beta interactions in human breast cancer progression
39. Excessive production of transforming growth-factor beta 1 can play an important role in the development of tumorigenesis by its action for angiogenesis: Validity of neutralizing antibodies to block tumor growth
40. Enhanced tumorigenesis and reduced transforming growth factor-beta type II receptor in lung tumors from mice with reduced gene dosage of transforming growth factor-beta1
41. Kip/Cip and Ink4 Cdk inhibitors cooperate to induce cell cycle arrest in response to TGF-beta
42. Immunocytochemical localization of secreted transforming growth factor-beta 1 to the advancing edges of primary tumors and to lymph node metastases of human mammary carcinoma
43. Induction of alpha-smooth muscle actin by transforming growth factor-beta 1 in quiescent human breast gland fibroblasts. Implications for myofibroblast generation in breast neoplasia
44. Transforming growth factor-beta 1 induces alpha-smooth muscle actin expression in granulation tissue myofibroblasts and in quiescent and growing cultured fibroblasts
45. Transforming growth factor-beta1 promotes the morphological and functional differentiation of the myofibroblast
46. The role of transforming growth factor beta 1 in the fibroblastic reaction associated with rat colorectal tumor development
47. Direct evidence for spatial and temporal regulation of transforming growth factor beta 1 expression during cutaneous wound healing
48. Transforming growth factor beta is essential for spindle cell conversion of mouse skin carcinoma in vivo: Implications for tumor invasion
49. TGFbeta signaling is necessary for carcinoma cell invasiveness and metastasis
50. TGF-beta signaling blockade inhibits PTHrP secretion by breast cancer cells and bone metastases development
51. Raf induces TGFbeta production while blocking its apoptotic but not invasive responses: A mechanism leading to increased malignancy in epithelial cells
52. Platelet-derived growth factor in autocrine transformation
53. Synthesis and secretion of platelet-derived growth factor by human breast cancer cell lines
54. Frequent expression of growth factors for mesenchymal cells in human mammary carcinoma cell lines
55. Production of PDGF-like growth factor by breast cancer cell lines
56. Platelet-derived growth factor (PDGF) in oncogenesis: Development of a vascular connective tissue stroma in xenotransplanted human melanoma producing PDGF-BB
57. Tumorigenic conversion of immortal human keratinocytes through stromal cell activation
58. Human breast carcinoma desmoplasia is PDGF initiated
59. Transforming growth factor beta reverses the glucocorticoid-induced wound-healing deficit in rats: Possible regulation in macrophages by platelet-derived growth factor
60. Mediation of wound-related Rous sarcoma virus tumorigenesis by TGF-beta
61. Angiogenesis in cancer and other diseases
62. Vascular endothelial growth factor (VEGF) and its receptors
63. Vascular permeability factor (vascular endothelial growth factor) expression and angiogenesis in patients with ductal carcinoma in situ of the breast
64. Expression of vascular permeability factor (vascular endothelial growth factor) and its receptors in breast cancer
65. Basement membrane components (Matrigel) promote the tumorigenicity of human breast adenocarcinoma MCF7 cells and provide an in vivo model to assess the responsiveness of cells to estrogen
66. Enhanced tumor growth of both primary and established human and murine tumor cells in athymic mice after coinjection with Matrigel
67. Basement membrane complexes with biological activity
68. The role ofstroma in breast carcinoma growth in vivo
69. Human breast cancer cell lines as models of growth regulation and disease progression
70. Analysis of insulin-like growth factor I gene expression in malignancy: Evidence for a paracrine role in human breast cancer
71. Insulin-like growth factor expression in breast cancer epithelium and stroma
72. Insulin-like growth factor mediated stromal-epithelial interactions in human breast cancer
73. The roles of hepatocyte growth factor/scatter factor and Met receptor in human cancers
74. Met-HGF/SF: Tumorigenesis, invasion and metastasis
75. Expression of scatter factor and c-Met receptor in benign and malignant breast tissue
76. Regulation of fibroblast hepatocyte growth factor/scatter factor expression by human breast carcinoma cell lines and peptide growth factors
77. Induction of epithelial tubular morphogenesis in vitro by fibroblast-derived soluble factors
78. Differential immuno-histochemical detection of transforming growth factor alpha, amphiregulin and CRIPTO in human normal and malignant breast tissues
79. Expression of messenger RNA for amphiregulin, heregulin, and cripto-1, three new members of the epidermal growth factor family, in human breast carcinomas
80. The significance of heregulin in breast cancer tumor progression and drug resistance
81. Clinicopathologic analysis of amphiregulin and heregulin immunostaining in breast neoplasia
82. The role of the epidermal growth factor receptor family in mammary tumorigenesis and metastasis
83. Epidermal growth factor and amphiregulin up-regulate matrix metalloproteinase-9 (MMP-9) in human breast cancer cells
84. Epidermal growth factor-like ligands differentially up-regulate matrix metalloproteinase 9 in head and neck squamous carcinoma cells
85. Extracellular matrix remodelling and cellular differentiation
86. The degradation of human endothelial cell-derived perlecan and release of bound basic fibroblast growth factor by stromelysin, collagenase, plasmin, and heparanases
87. Wnt signaling and cancer
88. A retrovirus vector expressing the putative mammary oncogene iht-1 causes partial transformation of a mammary epithelial cell line
89. Wnt-1 induces growth, cytosolic beta-catenin, and Tcf/Lef transcriptional activation in Rat-1 fibroblasts
90. Neoplastic transformation of RK3E by mutant beta-catenin requires deregulation of Tcf/Lef transcription but not activation of c-myc expression
91. Identification of c-MYC as a target of the APC pathway
92. Beta-catenin regulates expression of cyclin D1 in colon carcinoma cells
93. WISP genes are members of the connective tissue growth factor family that are up-regulated in wnt-1-transformed cells and aberrantly expressed in human colon tumors
94. The connective tissue growth factor/cysteine-rich 61/nephroblastoma overexpressed (CCN) family
95. The CCN family of angiogenic regulators: The integrin connection
96. WISP-1 is a Wnt-1- and beta-catenin-responsive oncogene
97. Matrix metalloproteinases: Multifunctional contributors to tumor progression
98. Changing views of the role of matrix metalloproteinases in metastasis
99. The significance of matrix metalloproteinases during early stages of tumor progression
100. Inhibition of stromal matrix metalloproteases: Effects on breast-tumor promotion by fibroblasts
101. Expression and localization of matrix-degrading metalloproteinases during colorectal tumorigenesis
102. Expression of most matrix metalloproteinase family members in breast cancer represents a tumor-induced host response
103. Stromelysin 3 belongs to a subgroup of proteinases expressed in breast carcinoma fibroblastic cells and possibly implicated in tumor progression
104. A novel metalloproteinase gene specifically expressed in stromal cells of breast carcinomas
105. Stromelysin-3 in stromal tissue as a control factor in breast cancer behavior
106. Correlation between stromelysin-3 mRNA level and outcome of human breast cancer
107. In vivo evidence that the stromelysin-3 metalloproteinase contributes in a paracrine manner to epithelial cell malignancy
108. Angiogenesis: How a tumor adapts to hypoxia
109. Matrix metalloproteinase-9 triggers the angiogenic switch during carcinogenesis
110. Cell surface-localized matrix metalloproteinase-9 proteolytically activates TGF-beta and promotes tumor invasion and angiogenesis
111. The mast cell: Origin, morphology, distribution, and function
112. Molecular bases of dominant negative and loss of function mutations at the murine c-kit/white spotting locus: W37, Wv, W41 and W
113. Inflammatory mast cells up-regulate angiogenesis during squamous epithelial carcinogenesis
114. The urokinase-type plasminogen activator system in cancer metastasis: A review
115. The urokinase plasminogen activator system as a target for prognostic studies in breast cancer
116. Urokinase plasminogen activator: A prognostic marker in multiple types of cancer
117. Receptor for urokinase is present in tumor-associated macrophages in ductal breast carcinoma
118. Urokinase-type plasminogen activator is expressed in stromal cells and its receptor in cancer cells at invasive foci in human colon adenocarcinomas
119. Messenger RNA for urokinase plasminogen activator is expressed in myofibroblasts adjacent to cancer cells in human breast cancer
120. Regional variations of urokinase-type plasminogen activator in human colorectal cancer: A quantitative study by image analysis
121. Cytokine-regulated urokinase-type-plasminogen-activator (uPA) production by human breast fibroblasts in vitro
122. Tumor development is retarded in mice lacking the gene for urokinase-type plasminogen activator or its inhibitor, plasminogen activator inhibitor-1
123. Fibrin gel investment associated with line 1 and line 10 solid tumor growth, angiogenesis, and fibroplasia in guinea pigs. Role of cellular immunity, myofibroblasts, microvascular damage, and infarction in line 1 tumor regression
124. Increased invasion and spontaneous metastasis of BL6 melanoma with inhibition of the desmoplastic response in C57 BL/6 mice
125. Lysyl oxidase gene expression in the stromal reaction to in situ and invasive ductal breast carcinoma
126. Lysyl oxidase-like protein localizes to sites of de novo fibrinogenesis in fibrosis and in the early stromal reaction of ductal breast carcinomas
127. Fibrosis in immune control of mammary-tumor growth
128. Macrophage functions are regulated by murine decidual and tumor extracellular matrices
129. Regulation of immune responses by TGF-beta
130. Heterotransplants of human tumors in nude mice
131. The vascular endothelial growth factor (VEGF) isoforms: Differential deposition into the subepithelial extracellular matrix and bioactivity of extracellular matrix-bound VEGF